Natural Product Sciences

  • 제25권2호
  • /
  • Pages.111-114
  • /
  • 2019
  • /
  • 1226-3907(pISSN)
  • /
  • 2288-9027(eISSN)
한국생약학회 (The Korean Society of Pharmacognosy)
권호 표지
DOI QR코드

DOI QR Code

Simultaneous Analysis of Four Standards of The Herbal Formula, DF-02, of Ephedra intermedia and Rheum palmatum, using by High Performance Liquid Chromatography-Ultraviolet Detector (HPLC-UVD)

  • Choi, Seong Yeon (College of Pharmacy, Kangwon National University) ;
  • Jeong, Birang (College of Pharmacy, Kangwon National University) ;
  • Jang, Hyeon Seok (College of Pharmacy, Kangwon National University) ;
  • Lee, Jiho (College of Pharmacy, Kangwon National University) ;
  • Kwon, Yong Soo (College of Pharmacy, Kangwon National University) ;
  • Yoon, Yoosik (Department of Microbiology, College of Medicine, Chung-Ang University) ;
  • Shin, Soon Shik (Department of Formula Sciences, College of Korean Medicine, Dong-Eui University) ;
  • Yang, Heejung (College of Pharmacy, Kangwon National University)
  • 투고 : 2018.11.11
  • 심사 : 2018.12.09
  • 발행 : 2019.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The herbal formula, DF-02, consisting of Ephedra intermedia and Rheum palmatum are used for the treatment of the metabolic diseases such as obesity and liver fibrosis in Korean local clinics. We aimed to develop the simultaneous analytical conditions for four standards, (+)-pseudoephedrine (PSEP) and (-)-ephedrine (EP) for E. intermedia, and aloe-emodin (AE) and chrysophanol (CP) for R. palmatum using HPLC-UV techniques. The validated conditions yielded the high precision (relative standard deviation (RSD) < 3.65%) and the recoveries (94 - 106%) using the calibration curves with high linearity ($R^2$ > 0.9994). As a result, four standards of DF-02 were simultaneously determined under the developed method, which will be utilized for the quality control or evaluation of DF-02 and many herbal preparations containing E. intermedia and R. palmatum.

키워드

참고문헌

  1. Jeong, B.; Choi, S. Y.; Jang, H. S.; Yoo, G.; Kim, S. H.; Kim, J.; Kwon, Y. S.; Roh, J. S.; Yoon, Y.; Shin, S. S. Nat. Prod. Sci. 2017, 23, 9-15. https://doi.org/10.20307/nps.2017.23.1.9
  2. Kee, C. H. The Pharmacology of Chinese Herbs; CRC Press: U.S.A., 1999, p 308.
  3. Yamada, I.; Goto, T.; Takeuchi, S.; Ohshima, S.; Yoneyama, K.; Shibuya, T.; Kataoka, E.; Segawa, D.; Sato, W.; Dohmen, T.; Anezaki, Y.; Ishii, H.; Ohnishi, H. Cytokine. 2008, 41, 293-301. https://doi.org/10.1016/j.cyto.2007.12.003
  4. Ma, G.; Bavadekar, S. A.; Davis, Y. M.; Lalchandani, S. G.; Nagmani, R.; Schaneberg, B. T.; Khan, I. A.; Feller, D. R. J. Pharmacol. Exp. Ther. 2007, 322, 214-221. https://doi.org/10.1124/jpet.107.120709
  5. Fleming, R. M. Expert Opin. Drug Saf. 2008, 7, 749-759. https://doi.org/10.1517/14740330802510915
  6. Chen, D. C.; Wang, L. Chin. J. Traumatol. 2009, 12, 365-369. https://doi.org/10.3760/cma.j.issn.1008-1275.2009.06.008
  7. Barceloux, D. G. Dis. Mon. 2009, 55, 403-411. https://doi.org/10.1016/j.disamonth.2009.03.011
  8. Sheu, S.; Huang, M. J. Food Drug Anal. 2000, 8, 337-341.

피인용 문헌

  1. A Review on Worldwide Ephedra History and Story: From Fossils to Natural Products Mass Spectroscopy Characterization and Biopharmacotherapy Potential vol.2020, 2019, https://doi.org/10.1155/2020/1540638